A-1 Drug Screening & Compliance Services Inc is categorized under in Irvine, CA and active since 2013.
A-1 Drug Screening & Compliance Services Inc was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 446110 by the NAICS.
If you are seeking more information, feel free to contact Robert Kechian at the company’s single location by writing to 15333 Culver Drive 340-344, Irvine, California CA 92604 or by phoning (949) 679-5627. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | A-1 Drug Screening & Compliance Services Inc |
| Contact Person: | Robert Kechian |
| Address: | 15333 Culver Drive 340-344, Irvine, California 92604 |
| Phone Number: | (949) 679-5627 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 446110 |
| Share This Business: |
A-1 Drug Screening & Compliance Services Inc was started in 2013 to provide professional under the SIC code 5912 and NAICS code 446110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Kechian for inquiries that concern A-1 Drug Screening & Compliance Services Inc by calling the company number (949) 679-5627, as your correspondence is most welcome. Additionally, the physical location of the single location of A-1 Drug Screening & Compliance Services Inc can be found at the coordinates 33.695482,-117.797295 as well as the street address 15333 Culver Drive 340-344 in Irvine, California 92604.
For its online presence, you may visit A-1 Drug Screening & Compliance Services Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.